发明名称 Modified IGF1 polypeptides with increased stability and potency
摘要 A targeting fusion protein comprising a component that comprises a (i) ligand or derivative or fragment thereof that binds a pre-selected target surface protein, such as a receptor, and (ii) an active agent or therapeutic agent(s), and further optionally (iii) a multimerizing component and/or (iv) a signal sequence. In a preferred embodiment, the targeting fusion polypeptide targets muscle and is useful to treat a muscle-related disease or condition, such as muscle atrophy.
申请公布号 US7355018(B2) 申请公布日期 2008.04.08
申请号 US20040954468 申请日期 2004.09.30
申请人 REGENERON PHARMACEUTICALS, INC. 发明人 GLASS DAVID J.
分类号 A61K38/24;A61K38/00;A61K38/27;A61K38/30;A61K39/395;C07H21/04;C07K14/475;C07K14/65;C07K14/705;C07K16/46;C07K17/00;C12N15/62;C12P21/06;C12P21/08 主分类号 A61K38/24
代理机构 代理人
主权项
地址